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What is Urban Health Policy and What's Law Got 
To Do With It? 
Larry I. Palmer* 
''The experts concluded that if the community were to be healthy, if it were not 
to revert again to a blighted or slum area, as though possessed of a congenital 
disease, the area must be planned as a whole. It was not enough, they believed, 
to remove existing buildings that were insanitary [sic] or unsightly."1 
More than half the world's population now lives in cities? Legal scholars are 
beginning to explore the global implications of urban poverty on the .health of 
various segments of the population. 3 Scholars from a variety of disciplines have 
assumed that our domestic policy problems such as health disparities-however 
defined-will be solved by enactment of various pieces of national legislation. 
Even those whose ideological commitments lead them to favor "market-based" 
solutions over government involvement in the "health care reform" debate 
assume the need for national or state solutions in the form of tax incentives or 
deregulation.4 
I propose to enrich scholarship and discourse on health policy by shifting the 
focus away from global, national, and state action to that which is most 
local-the neighborhood, the community, and the city.5 Our public discourse no 
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my seminar, Emerging Problems of Urban Public Health, who raised many provocative questions about 
my approach. I further wish to acknowledge the assistance of Juliana Frisch, The College of William & 
Mary Law School Class of 2008 and Lea!I Kaufman, The College of William & Mary Law School Class 
of 20 I 0 for their assistance with the footnotes. © 2009, Larry L Palmer. 
1. Berman v. Parker, 348U.S. 26,34 (1954) (upholding the constitutionality of legislation authorizing 
"urban renewal" that allowed a public condemnation of commercially "healthy" property to be turned 
over to a private developer for demolition). 
2. UNITED NATIONS POPULATION FuND, STATE OF WORLD POPULATION 2007: UNLEASHING THE 
PoTENTIAL OF URBAN GROWTH 1 (2007), available at· http://www.unfpa.org/swp/2007/presskit/pdf/ 
sowp2007 _eng.pdf (last visited Nov. 9, 2008). 
3. See generally Lawrence 0. Gostin, Meeting Basic Survival Needs of the Worlds Least Healthy 
People Toward a Framework Convention on Global Health, 96 GEo. L.J. 331 (2008) (arguing in part that 
the poorest people in the poorest countries have the worst health, and that this has effects across the 
globe). 
4. See, e.g., John McCain 2008, Straight Talk on Health System Reform, http://www.johnmccain.com/ 
lnformingllssues/19ba2flc-c03f-4ac2-8cd5-5cf2edb527cf.htm (last visited July 28, 2008). 
5. What constitutes a city or urban area is a matter of state law in this country and has been recently 
undergoing change as some traditional cities have combined with the surrounding counties to form 
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longer embraces Justice Douglas' metaphor of the city as inherently sick as a 
social and physical phenomenon, or, in his words, as "possessed of a congenital 
disease."6 We are just as likely to hear calls for a "new urbanism" that decries the 
ill health consequences of "suburban sprawl" as a sort of panacea for a host of 
health issues facing the nation. 7 
Yet there are reminders of our lack of understanding about the nature of 
modern urban living in the attempted rebuilding of parts of New Orleans and 
other Gulf Coast cities after Hurricanes Katrina and Rita. In the immediate 
aftermath of the flooding in 2005, it was as if the nation discovered for the first 
time that there were poor people living beyond the French Quarter in New 
Orleans. Old fashioned public health concerns-dean water, sewage, retrieval of 
bodies, and so on-were the subject of the nightly news. 8 The term "refugees" 
was used to describe residents of an American city when they sought reprieve 
from rising flood waters.9 Despite promises by politicians at all levels of 
government to "rebuild" New Orleans, many of us wonder if a city with the 
population and the ethnic, racial, and socio-economic diversity of New Orleans 
as of August 2005 will ever exist again in our lifetimes. 10 Whatever the 
demographic and physical layout of_ the "new" New Orleans, it is increasingly 
clear that we do not understand how statutes, regulations, and court decisions at 
metropolitan governments, such as in Louisville, Kentucky, Memphis, Tennessee, and Indianapolis, 
Indiana. See IND. CoDE ANN. § 36-3-1-1 (LexisNexis 2008) (the merger of Indianapolis and Marion 
County, known as UniGov, began in 1970 and was ordered by state legislation); KY. REv. STAT. ANN. 
§ 67C.101 (LexisNexis 2008) (the merger of Louisville and Jefferson County began in 2003 via a · 
referendum, for which the legislature gave permission through special legislation); TENN. CODE. ANN. 
§ 7-1-101(4), (5) (2007) (providing definitions for "metropolitan government" and "metropolitan 
government charter commission"). See also FRANK GAMRAT & JAKE HAULK, ALLEGHENY INST. FOR PuB. 
POLICY, MERGING GOVERNMENTS: LESSONS FROM LoUISVILLE, INDIANAPOLIS, AND PHILADELPIDA (2005), 
available at http://www.alleghenyinstitute.org/reports/05_04.pdf (last visited Nov. 9, 2008) (providing 
an overview of the processes in Louisville, Indianapolis, and Phihidelphia). 
6. Berman, 348 U.S. at 34 (emphasis added). 
7. See, e.g., Ernie Hood, Dwelling Disparities: How Poor Housing Leads to Poor Health, 113 ENVTL 
HEALTH PERSP. A310 (2005); David E. Jacobs, Tom Kelly & John Sobolewski, Linking Public Health, 
Housing, and Indoor Environmental Policy: Successes and Challenges at Local and Federal Agencies in 
the United States, 115 ENVTL HEALTH PERSP. 976 (2007); Jennifer Medlin, Dwelling on Differences in 
Health, 113 ENVTL HEALTH PERSP. A592 (2005). 
8. See, e.g., Elizabeth Agnvall, Next Threat: Illness; Experts Anxious to Contain Disease Outbreaks, 
Rumors, WASH. PosT, Sept. 13, 2005, at F01; Timothy Dwyer & Michael A. Fletcher, Residents Stay Put, 
Despite Orders; Officials Warn of Floodwaters' Health Threat, WASH. PosT, Sept. 8, 2005, at A13; 
Jessica Heslam, Katrina's Wrath: Health Crisis Looms in Bayou, BosTON HERALD, Sept. 1, 2005, at 2; 
Robert D. McFadden & Ralph Blumenthal, Bush Sees Long Recovery for New Orleans, N.Y. TIMEs, Sept. 
1, 2005, atA1; Bruce Nichols, Waterborne Bacteria Suspected in Some Deaths, DALLAs MORNING NEWS, 
Sept. 8, 2005, at 1A; Jonathan D. Rockoff, Health Officials Focus on Infectious Diseases, BALT. SUN, 
Sept. 7, 2005, at lOA. 
9. See, e.g., Calling Katrina Survivors 'Refugees' Stirs Debate, AsSOCIA'!JlD PREss, Sept. 7, 2005, 
available at http://www.msnbc.msn.com/id/92320711 (last visited Nov. 15, 2009). 
10. Cf, e.g., Jenny Jarvie, A Fury in New Orleans as Housing Demolition Okd; Protesters, Police 
Clash During a City Council Hearing Where a Plan to Raze Public Projects is Unanimously Approved, 
L.A. TIMEs, Dec. 21, 2007, at A19; Adam Nossiter & Leslie Eaton, New Orleans Council Votes for 
Demolition of Housing, N.Y. TIMEs, Dec. 21,2007, atA37. 
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every level of government affect where people live and how that "built 
environment" conditions individual and collective health risks. One symbol of 
our concern for what is happening not only in New Orleans, but in many older 
cities 11 across this country, is the indefinite closure of Charity Hospital-often 
called Big Charity for its public service to the poor-in New Orleans. 12 
I propose to -shed light on analytical methods likely to generate solutions to 
post-Katrina confusion by focusing on.a question: What is urban health policy? 
This question is useful in the current era when many assume that anything not 
based on science or black-letter legal precedent should be lumped under the 
vague rubric of "policy." This misconception assumes "values" or "emotions"13 
are the primary drivers of decision-making. When this notion is applied to health 
policy, we further make a normative assumption that different perspectives on 
health risk are best navigated by the political and regulatory processes and 
avoided by courts. My answer here is grounded in the scholarship of institutional 
choice. 14 Using a form of comparative institutional analysis, I will also answer 
the subsidiary question of what role law plays in urban health policy by 
illustrating how various Iegai institutions-courts, legislatures, regulatory bodies 
of various kinds-and "the market" become the primary forum for policy-
making. Such an analytical approach may assist us to see the limits of law in 
some instances, but also illuminates instances in which the law has provided 
incentives for social and economic institutions adverse to the health and 
well-being of the most vulnerable in our urban communities. Ultimately, my 
analysis emphasizes that lawyers should view health policy discourse as 
intrinsically multidisciplinary, even when we are engaged in litigation before 
courts. 
My analysis is in four parts. Part I develops a framework for defining urban 
health policy in· the context of an institutional analysis of law. I propose that the 
11. None of MONEY Magazine's ten best cities to live in are what I would refer to as an "older city." 
See Kate Ashford, eta!., Best Places to Live, MoNEY, Aug. 2007, available at http://money.cnn.com/ 
galleries/2007/moneymag/0707/gallery.BPTL_top_lOO.moneymag/index.htrnl (last visited Nov. 9, 2008) 
(reporting that the ten best cities are Middleton, Wisconsin, Hanover, New Hampshire, Louisville, 
Colorado, Lake Mary, Florida, Claremont, California, Papillion, Nebraska, Milton, Massachusetts, 
Chaska, Minnesota, Nether Providence, Pennsylvania, and Suwanee, Georgia). 
12. For more about the closure of public hospitals in Louisiana, see generally Elizabeth A. Weeks, 
Shaping A New Direction for Law and Medicine: An International Debate on Culture, Disaster, 
Biotechnology and Public Health, 10 DePaul J. Health CareL. 251 (2007). For more on the closure of 
public hospitals as a general matter, see generally Julie J. Piotrowski, How Secure is the Safety Net? 
Public Hospitals Learn to Survive in an Increasingly Tight Market by Closing, Building, Replacing, and 
Sometimes Converting, Modem Healthcare 32, no. 8 (2002). 
13. Cf MARTHA NUSSBAUM, UPHEAVALS OF THOUGHT: THE INTELLIGENCE OF EMOTIONS 420-25 (2001) 
(arguing that empathy could influence the way judges construct issues). 
14. See generally, e.g., NEIL K. KOMESAR, LAW'S LIMITS: THE RULE OF LAW AND TilE SUFPLY AND 
DEMAND OF RIGHTS (2001); William W. Buzbeee, Sprawl's Dynamics: A Comparative Institutional 
Critique, 35 WAKE FoREST L. REv. 509 (2000). See also Nancy J. Knauer, The Recognition of Same-Sex 
Relationships: Comparative Institutional Analysis, Contested Social Goals, and Strategic Institutional 
Choice, 28 U. HAw. L. REv. 23 (2006). 
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Supreme Court's opinion in Berman v. Parker15 illustrates the continuing debate 
over the role courts play in shaping the built environment of cities in the United 
States. Relying solely on the analysis of courts as emblematic of the Rule of Law, 
however, ignores the dynamic nature of the impact that legal institutions-
including courts at the local and state level, as well as political bodies at various 
levels of government-have on shaping the social ecology of American cities, 
together with social and demographic factors. Combining a market analysis with 
a systemic approach to analyzing the impact that legal institutions have on that 
market produces a set of empirical questions all legal institutions must address. 
The dearth or uncertainty of data central to a particular issue is not a limitation 
that affects only the courts; it impacts political bodies as well. 16 
Part II uses this institutional definition of urban health policy to analyze the 
problem encountered by researchers conducting empirical studies about "healthy" 
and "unhealthy" housing. There has been considerable commentary on litigation 
over attempts to find cost effective means to eliminate health risks posed by lead 
paint in older urban dwellings. 17 What has not been fully discussed is the ongoing 
shift in how we frame the problem of unhealthy housing in. urban areas. Rather 
. than seek the surgical removal of blighted housing, as was done in the era of 
urban renewal, the emphasis has shifted to "curing" lead-laden housing of its 
illness. This new emphasis on restoring existing housing stock comes at a time 
when the federal government is supporting the replacement of older public 
housing projects with mixed income housing. 18 In addition, little attention has 
been paid to the response of other institutions to the Maryland court's decision in 
Grimes v. Kennedy Kreiger, which held that a research organization could be 
liable for a faulty consent process in lead paint research. Kennedy Krieger has 
negatively impacted the ability of empirical scientists to gather data on the effects 
housing has on its residents. Political bodies have responded to the opinion, but 
not in the way desired by in the dissent in Kennedy Kreiger, or by public interest 
parties involved in the case. 19 Of even greater significance is the response of the 
research community and its allies in the federal agencies that fund most housing 
15. See generally Berman, 348 U.S. 26. 
16. See KOMESAR, supra note 14. 
17. See Grimes v. Kennedy Krieger Inst., Inc., 782 A.2d 807 (Md. 2001). Most legal commentary on 
Kennedy Krieger focuses on bioethical issues, informed consent, and experimental procedures. See, e.g., 
Carl H. Coleman, Duties to Subjects in Clinical Research, 58 VAND. L. REv. 387,431-32 (2005); Doriane 
Lan~belet Coleman, The Legal Ethics of Pediatric Research, 57 DuKE L.J. 517, 523-603 (2007); Russell 
Korobkin, Autonomy and Informed Consent in Nontherapeutic Biomedical Research, 54 UCLA L. REv. 
605,614 (2007). 
18. See, e.g., U.S. Department of Housing and Urban Development, HOPE VI, http://www.hud.gov/ 
offices/pih/programs/phlhope6/ (last visited Nov. 9, 2008). For a critique of HOPE VI, see NATIONAL 
HOUSING LAW PROJECT, ET AL., FALSE HOPE: A CRrnCAL ASSESSMENT OF THE HoPE VI PuBuc HOUSING 
REDEVELOPMENT PROGRAM (2002). 
19. Kennedy Krieger, 782 A.2d at 862 (Raker, J., dissenting) (arguing that the issue of a parent or 
guardian' ability to consent to the participation of a minor child in a nontherapeutic research study is an 
important public policy consideration best dealt with by the legislature). 
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research. Once again, the response differs from what researchers and research 
organizations involved in Kennedy Krieger might have wanted.20 This more 
nuanced analysis of the various institutional actors involved in healthy housing 
problems illustrates that a new actor--one for the moment identified as "the 
community" -must become involved, not only in creating solutions to the 
healthy housing problem, but also in formulating the research questions 
themselves?1 More generally, I contend that the shift in framing the healthy 
housing problem, from surgical cure to renewal and restoration of a community, 
illustrates that policy development and policy-making are two different types of 
processes in public health systems. 
Part ill uses the legislative debate over mandating the Human Papillomavirus 
(HPV) vaccine and the New York City?s diabetes surveillance regulations to 
argue that the legal tools of the "old public health" will not be effective in the 
"new public health" milieu?2 Noble goals, such as ensuring the most vulnerable 
populations receive vaccination or optimal diabetes management, by themselves 
will not solve the complex questions of whether law, in whatever form, does or 
can achieve the optimal amount of health in an urban population, or any subgroup 
within that population. The new public health is not simply a matter of public 
health officials assuming new conditions to be within the purview. of their 
expertise or function. Rather, the science underlying public health must now 
incorporate the new knowledge generated by genomics?3 An HPV vaccine 
represents a new definition of how to interrupt the disease process that would not 
have been possible prior to the Human Genome Project. 24 Furthermore, the 
global social and economic systems render the traditional public health tools-
legal isolation and quarantine--of limited utility as old diseases such as 
tuberculosis evolve. My critique points to the need for a new legal framework 
rather than the traditional balancing of interests analysis?5 
20. See generally ETIIICAL CONSIDERATION FOR REsEARCH ON HOUSlNG RELATED HEALTH HAzARDS 
lNVOLYlNG CHILDREN (Bernard Lo & Mary Ellen O'Connell eds., 2005). 
21. See generally DA VYDD GREENWOOD & MORTEN LEYlN, INTRODUCTION TO ACTION REsEARCH: 
SociAL REsEARCH FOR SOC1AL CHANGE (2nd ed. 2007). 
22. The "new" public health has been characterized as a broad-based private and public effort to 
reduce the social burdens of disease, including chronic diseases such as diabetes, obesity, and cancer. 
Compare Richard A. Epstein, Let the Shoemaker Stick to His Last: A Defense of the "Old" Public Health, 
46 PERSP. BIOLOGY & MED. 5138, 5139 (Supp. 2003) (arguing against broad regulatory intervention in 
areas of public health outside traditional notions of infectious diseases and epidemics) with Lawrence 0. 
Gostin & M. Gregg Bloche, The Politics of Public Health: A Response to Epstein, 46 PERSP. BIOLOGY & 
MED. S 160, S 163-165 (Supp. 2003) (arguing that regulatory intervention is justified if there is strong data 
suggesting the need for far-reaching public health interventions). 
23. See generally, WHO WlLL KEEP THE PuBLIC HEALTHY?: EDUCATING PuBLIC HEALTH PROFESSION-
ALS FOR THE 21sr CENTURY (Kristine Gebbie et al. eds., 2002). 
24. See Larry I. Palmer, Disease Management and Liability in the Human Genome Era, 47 VlLL. L. 
REv. 1, 2 (2002). 
25. Cf AmyL. Fairchild, Diabetes and Disease Surveillance, 313 SCIENCE 175, 176 (2006) (arguing 
for a gloss on traditional balancing of privacy and public health by suggesting a distinction between soft 
and hard paternalism). · 
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Part IV uses the problem of cardiovascular research and risk to illustrate that 
health policy must incorporate social and economic costs into its legal analysis 
without falling victim to the false promises of "consumer driven health care."26 
Cardiovascular treatment and prevention is an area of health care delivery whose 
cost effectiveness has been studied extensively, perhaps because of the rate of 
innovation in the field as a consequence of new drugs, surgical techniques, and 
devices for assisting or replacing heart functions?7 On the other hand, many of 
the conditions affecting vulnerable urban populations-for instance, obesity and 
diabetes~increase the risk of cardiovascular disease. Therefore, framing the 
problem mote broadly as cardiovascular risk and research allows for consider-
ation of these additional factors in determining what data is needed to arrive at an 
effective policy.28 The most important insight from this application of compara-
tive institutional analysis to a problem in urban health is the discovery that 
attempts to measure "cost" should be replaced by efforts to measure "value" to 
patients?9 · 
I. Do CITIES MAKE PEOPLE HEAL THIER? 
At the tum of the last century, industrial cities were the antithesis of a healthy 
built environment. The relatively well-off among city dwellers retreated to their 
summer places for fresh-and presumably cleaner and healthier-air. This literal 
and imaginative escape from the social and ecological lows of cities-polluted 
air, crime, overcrowded housing, and traffic congestion-led to two parallel 
. movements after World War II: urban renewal (the destruction of older residences 
and businesses and their replacement by new construction),30 and a strong 
preference among Americans for suburban living away from urban centers. 
Early migration from the urban center was built around rail (streetcar) 
transportation during the early twentieth century.31 Transportation technology-
26. See generally, CONSUMER-DRIVEN HEALTH CARE: IMPLICATIONS FOR PROVIDERS, PAYERS AND 
PoLICY MAKERS (Regina E. Herzlinger ed. 2004). Herzlinger argues that consumer control will "reward 
innovative insurers and providers for creating the higher-quality, lower-cost services we want and 
deserve. In this consumer-driven system, government will protect us with financial assistance and 
oversight, not micromanagement." /d. at xvii. 
27. The AbioCor implantable heart is only the latest in a long list of cardiac assist devices. See, e.g., 
AbioMed, http://www.abiomed.com/products/index.cfm (last visited Nov. 9, 2008). 
28. We should be mindful that determining what data to use in studies of health disparities generally is 
itself a problem for researchers and policy makers. See Risa Lavizzo-Mourey & James R. Knickman, 
Racial Disparities-The Need for Social Action, 349 NEw ENG. J. MED. 1379, 1380 (Oct. 2. 2003). 
29. See MICHAEL E. PORTER AND ELIZABETH OLMSTED Th:ISBERG, REDEFlNlNG HEALTH CARE 97, 99 
(2006). 
30. For a short overview of the legislative and legal history of "fighting blight," see Colin Gordon, 
Blighting the Way: Urban Renewal, Economic Development, and the Elusive Definition of Blight, 31 
FORDHAM URB. L.J. 305,311-312,315 (2004). 
31. See, e.g., The Official Website for the City of Richmond, VIrginia, Department of Economic 
Development, http://www.richmondgov.com/departrnents/econdev /mbe/history.aspx (last visited Nov. 9, 
2008) (pointing out that Richmond, Vrrginia had the world's first successful electric street car system). 
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particularly the widespread use of the automobile-along with a number of 
changes in federal, state, and local zoning laws surrounding the· financing of 
highways, the construction of new housing, and the uses of land gave rise to the 
current social and demographic structure of the suburbs. Zoning law-something 
that is almost always a matter of local control-is one of the chief vectors 
enabling development of the modem suburban subdivision. Single use zoning 
gave rise to suburbanizing developments like the archetypal Levittown, Long 
Island, where the mixed-use buildings so common in urban settings, such as 
residential space above a retail establishment, were prohibited in favor of 
single-use structures. 32 Embedded within zoning laws were social policies that 
contrasted with the goal of the city as a center of economic, social, racial, and 
ethnic diversity. 33 Justice Douglas, writing on behalf of the Supreme Court in 
1974, concluded in Village of Belle Terre v. Boraas that a local zoning ordinance 
limiting the number of unrelated persons living in a single "family" residence 
was constitutional.34 Justice Douglas was perhaps imagining a community that 
was not a city, but a "village" that could use the local political process to preserve 
a certain commonality among residents. At. a technicalleve( the Court held only 
that local government has enough latitude under the Constitution to develop a 
statutory definition of "family" that applied only to zoning laws. 35 More broadly, 
the decision indicated that local political processes would be the locus of 
decision-making for what public health scholars now identify as the "built 
environment."36 
Justice Marshall's dissent in Belle Terre foresaw many social disadvantages of 
the opinion's vision of community. The victims of "family zoning" in the case 
before the court were college students seeking to rent a house. Justice Marshall 
perceived the potential impact of the decision on the disadvantaged or members 
of minority groups who might seek to live in a given "village.'m A plurality of 
the Court in a subsequent case, Moore v. City of East Cleveland, Ohio, found it 
unconstitutional to apply a "family zoning" ordinance in such a way as to force a 
grandmother to remove one of her two grandsons, who were cousins rather than 
brothers, from her dwelling.38 Had the court ruled otherwise, the Moore family 
would have been tom apart because it.did not fit a very constrained definition of 
"family." One reason why courts might be reluctant to delve into underlying 
32. See, e.g., Joshua Ruff, Levittown: The Archetype for Suburban Development, http://www. 
historynet.comllevittown-the-archetype-for-suburban-development.htm (last visited Nov. 9, 2008); Matt 
Rosenberg, Levittown, http://geography.about.com/od/urbaneconomicgeography/a!levittown.htm (last 
visited Nov. 8, 2008). 
33. This vision of the city may not be that shared by everyone, and may in fact be contrary to some 
notions of community and neighborhood as articulated in community action research literature. 
34. Belle Terre v. Boraas, 416 U.S. 1 (1974). 
35. /d. at 8. 
36. See, e.g., KOMESAR, supra note 14. 
37. Belle Terre, 416 U.S. at 16-17 (Marshall, J., dissenting). 
38. Moore v. City of East Cleveland, 431 U.S. 494 (1977) (Powell, J., plurality opinion). 
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social issues in such zoning cases, however, is that the emotional-and therefore 
the political-impact of zoning decisions can be painfully intense because they 
impact in very fundamental way the manner in which people live and their sense 
of home, as well as, in some cases, homelessness. 
I suggest that most people concerned about poverty do not want to default to 
some notion of the "market" or the old public health law paradigm39 for 
determining where people live. We are becoming more aware of how thehousing 
market is currently structured by existing regulation as well as by deregulation.40 
We know that how individuals live is a combination of individual preference, 
economic and social conditions, and complex legal structures. We also know that 
how and where people live has some impact on their health-mental and 
physical.41 We have, however, neither a systemic way of thinking about the 
health impacts of living conditions nor the role of law or legal institutions in 
. defining those living conditions. This problem is symbolized by the variety of 
meanings we attribute to the term "health policy." The term could encompass 
everything from some idealized process in which policy makers use scientifically 
developed data to guide their decisions, to the often contentious process of 
obtaining local zoning variance for a home for the mentally disabled, or repealing 
the "tax subsidy" for health insurance prerniums.42 All disciplines, but in 
particular legal professionals, need to develop a clear definition of health policy. 
I propose a broader definition of health policy: It includes any attempt by 
private or public actors to shape the framing and resolution of decisions of 
institutional actors-the market, political processes, regulatory and administra-
tive processes, and courts-in the health system. The health system includes all 
processes that support health in a given society. It has two important subsystems, 
the health care delivery system and the public health system, which are of 
particular significance to the construction of the legal system. Urban health 
policy is thus defined by the conduct of institutional actors who influence the 
health systems of particular communities. I will illustrate how the growth in 
knowledge regarding health has changed the way that legal institutions respond 
to urban health issues. At the same time, I will delineate the role of regulatory 
agencies, legislatures and courts in developing health policy for urban areas. The 
role" of these legal institutions varies depending upon the particular locality's 
markets, political structures, and cultures, and the nature of the problem being 
addressed. I began with the problem of healthy housing because institutional 
39. See generally Esptein, supra note 22. 
40. The current mortgage crisis is an example of this understanding. Cf Emergency Economic 
Stabilization Act of 2008, HR 1424 (providing the federal government with authority to purchase certain 
"troubled assets" related to the mortgage crisis). 
41. There is plenty of evidence to support these intuitive assumptions, but this evidence is at best at the 
level of proving an "association" between living conditions and health. The gold standard of "causation" 
in public health sciences has not been met. 
42. See generally Mark V. Pauly, Blending Better Ingredients for Health Reform, Health Affairs 27, 
no. 6 (2008). 
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actors at every level-state, local, national, and even global43 -have some 
influence on the framing and optimizing of solutions. 
II. POLICY CHOICE: THE ROLE OF COURTS IN CREATING HEALTHY HOUSING 
The health risks created by lead paint in older housing stock are now a major 
issue in older cities. For instance, federal regulations prohibit the use of lead 
painting in residences built after 1978.44 Such regulations impose costs, leading 
some to argue that overregulation could impact the market by encouraging 
landlords to simply abandon older housing with lead paint. This regulatory and 
economic background provides part of the context for the case of Grimes v. 
Kennedy Krieger Institute,45 where the court held that a research organization 
could be liable for failures in the consent process in what I will call "healthy 
housing research." 
I frame Kennedy Krieger as a healthy housing research case rather than a case 
about "bioethics" or "public health ethics" for several reasons related to 
scholarship on institutional choice.46 First and foremost, scholarship on compara-
tive institutional analysis often starts with a case concerning with liability. These 
liability cases illustrate the need for courts to determine which institution is 
best-positioned to take responsibility for abating risk. The most famous of these 
cases, Boomer v. Atlantic Cement Company, 47 involves what we might call a 
public health problem in that the plaintiff landowners claimed the pollution from 
the plant created health risks to them. When the court ruled that the remedy for 
nuisance would be damages rather than an injunction, the court was suggesting 
that pollution (more broadly speaking, environmental health) was now a problem 
for political institutions rather than for courts.48 Thus, invoking a liability case to 
illustrate the analytical advantages of comparative institutional analysis is a 
technique used by many scholars following this approach to law and economics. 
It should be noted, however, that few scholars have used this approach on 
43. The sub-prime mortgage crisis is simply an illustration of how the financing of housing has 
become a global enterprise. See Martin Fackler, Global Finance Leaders Warn of Risk from U.S. Housing 
Woe, N.Y. TiMEs, Feb. 10,2008, atA16; MarkLandler, Housing Woes in U.S. Felt Around the Globe, N.Y. 
TiMEs, Apr. 14, 2008, at AI. 
44. Ban of Lead Containing-Paint and Certain Consumer Products Bearing Lead Containing-Paint, 16 
C.F.R. § 1303 (2008). See also, Residential Lead-Based Paint Hazard Reduction Act of 1992,42 U.S.C. 
§ 4851 (1992); 105 MASS. CODE REGS. 410.502 (2008). 
45. Kennedy Krieger, 782 A.2d 807. Part of the analysis developed in this paper started with my 
previous work, Larry I. Palmer, Genetic Health and Eugenics Precedents: A Voice of Caution, 30 FLA. ST. 
U. L. REv. 237, 241-52 (2003), but without the emphasis on the heed to build costs into the framework 
argued for in this paper. 
46. See KOMESAR, supra note 14. 
47. See generally Boomer v. Atlantic Cement Co., 257 N.E.2d 870 (N.Y. 1970). 
48. See KOMESAR, supra note 14, at 12-26 for an extensive discussion of this case and its implications 
for comparative institutional analysis. 
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problems of the health system.49 
Second, starting the analysis with Kennedy Krieger facilitates an explicit 
discussion of goals in legal and health policy analysis. One of the mantras of 
comparative institutional analysis is that social goals or values provide insuffi-
cient explanations for how institutional processes, including courts, operate.· 
Public health law, and in the case of Kennedy Krieger, public health research, is 
full of individuals with noble goals, which in the course of litigation are labeled 
pejoratively as having "conflicts of interests." I will illustrate that courts are in 
fact engaged in more than a hindsight analysis of the ethics of particular 
individuals or organizations or "balancing of interests." Rather, my analysis of 
Kennedy Krieger demonstrates that the various public and private individuals 
caught up in the court's process of adjudication are best characterized as "good 
people, operating under bad institutional arrangements."50 
Third, using a case provides a more nuanced understanding of the role _for 
courts in the debate over "who decides." Comparative institutional analysis is, in 
part, a critique of the over-emphasis in legal scholarship and education on the role 
of courts in resolving important social problems. On the other hand, courts are 
arguably the best (or the least bad) forum for framing, if not resolving, some 
controversial issues. I have argued, for example, that the abortion issue, or as I 
prefer to frame it, the issue of family formation, is for courts, acting as 
constitutional adjudicators, despite the deep religious and values conflict about 
the appropriateness of termination of pregnancy in particular. 5 1 Just because the 
United States Supreme Court frames the issue of family formation does not mean 
that the political process or state courts do not participate in constricting family 
formation decisions.52 Thus, Kennedy Krieger illustrates a situation in which 
state courts use common law notions of "duty" to allow disadvantaged urban 
dwellers to question the control of the "health knowledge market" by profession-
als and their organizations. By signaling that "market failures"-inadequate 
informed consent processes-might lead to court intervention, the court turns a 
new page in the debate about who should decide whose health is put at risk to 
discover the most cost efficient means of reducing health risks to a certain 
community. Rather than think of the case as a failure· to obtain appropriate 
informed consent, institutional analysis suggests this is a case about the duty to 
49. The issues of property law and the law of damages tends to dominate the scholarship on 
comparative institutional analysis, although Komesar acknowledges the applicability of the approach to 
health related issues. See his citation of my patient safety work in Law's Limits. KOMESAR, supra note 14, 
at 177. Even scholars concerned about the health of disadvantaged community frame the issues from the 
perspective of property law and the law of remedy. See, e.g., Rachel D. Godsil, Viewing the Cathedral 
from Behind the Color Line: Property Rules, Liability Rules and Environmental Racism, 53 EMORY L.J. 
1807 (2004). 
50. Larry I. Palmer, Paying for Suffering: The Problem of Human Experimentation, 56 MD. L. REv. 
604, 611 (1997). 
51. See LARRY I. PALMER, ENDING AND BEGINNINGS: LAW, MEDICINE & SOCIETY IN ASSISTED LIFE AND 
DEATH 45-51 (Praeger Publishers 2000). 
52. /d. 
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disclose certain information. 
Looking at the "facts" of Kennedy Krieger through the lens of institutional 
analysis encourages us to broaden the context before looking at the very narrow 
issue decided in the case. 53 But first consider the facts from the perspective of the 
narrowest legal question presented: Did the lower court err in granting summary 
judgment for the defendant under the facts as alleged by the plaintiffs? As the 
court described the issue: 
Was the trial court incorrect in ruling on a motion for summary judgment that as 
a matter of law a research entity conducting an ongoing non-therapeutic 
scientific study does not have a duty to warn a minor volunteer participant 
and/or his legal guardian regarding dangers present when the researcher has 
knowledge of the potential for harm to the subject and the subject is unaware of 
the danger?54 
There are a number of facts essential to answering this narrow question. The 
Kennedy Krieger Institute undertook a study to find the most cost-efficient way 
of reducing the health risks of lead paint in residences in the city of Baltimore. 
The study required the periodic testing of levels of lead present in the dwellings 
and as well as the levels of lead present in the blood of the children living in the 
dwellings. The plaintiffs were children whose lead blood level was at the "normal 
level" as determined by the guidelines developed by the Centers for Disease 
Control and Prevention (CDC). 55 These blood levels became above normal after 
testing indicated there was lead paint or "hot spots" in their dwellings. 56 There 
was a delay between Kennedy Krieger's receipt of the blood test results and their 
communication of the results to the parents or guardians of the plaintiffs. The 
court concluded that the Kennedy Krieger Institute might have a duty to warn the 
parents of their children's individual health risks discovered in the course of a 
lead paint abatement study involving their residences. 57 
As noted previously, there is considerable commentary on the court's broad 
discussion of the regulatory oversight of the research process. 58 Unlike many of 
those commentators, I believe the court understood that it was dealing with a 
major problem in urban health policy and sought to frame the debate about 
"healthy housing," not simply for courts, but for other institutions-legislatures, 
53. The dissenting judge proposes a narrow framing of the issue on the theory that the legislature 
ought to deal with the complexity of ethics and research policy implicit in the majority's ruling on 
summary judgment. What the legislature in fact did after the case, as will be discussed infra may indicate 
that majority was more aware of where the political process was on this type of research than the dissent. 
See Kennedy Krieger, 782 A.2d at 862. 
54. ld. at 818. 
55. /d. at 825. 
56. /d. 
57. /d. at 818-19. 
58. See sources cited in supra note 17. 
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regulatory bodies, and the professionals engaged in the knowledge market. The 
case is significant because the court explains the complexity of the problem in a 
way that establishes a role for courts without implying that a court can solve the 
healthy housing problem. Consider some of the salient things we discovered 
about the participants in the market and political processes surrounding lead in 
houses in the city of Baltimore. 
In our modem era, governmental agencies provide funds for research 
regarding many problems facing society. By the 1990s, federal and state agencies 
had concluded it was not economically feasible to remove all lead paint from 
older housing stock.59 Some of those agencies prov_ided the funds for Kennedy 
Krieger's research and helped individual researchers at Kennedy Krieger to 
develop a complex research network. The Environmental Protection Agency 
(EPA) provided a grant to the.Kennedy Krieger Institute to pay for some of the 
researchers' time as well as other expenses of the project.60 The two lead 
researchers on the projects held appointments· at Johns Hopkins Schools of 
Medicine and Public Health,61 ·and ·the Institutional Review Board at Johns 
Hopkins, apparently under contract, conducted the human subject review 
required by federal regulations for the Kennedy Krieger Institute.62 The 
researchers needed additional organizational partners to conduct this complex 
project because they needed to have dwellings with different levels of lead 
abatement and families with children living in those dwellings. 
To achieve these goals, the researchers facilitated loans from the Maryland 
Department of Housing and Community Development to landlords63 and enlisted 
a not-for-profit organization to assist with the recruitment of families with 
children to live in the various housing units.64 There was a Lead Hazard 
Abatement Research Department at Kennedy Krieger in 200265 and the Institute 
was the major center for testing for lead poisoning in Maryland and surrounding 
states. The individual researchers were thus able to act as "knowledge entrepre-
neurs" prior to the litigation partially because of their affiliation with an 
organization that took a systemic approach to the problem of childhood 
disabilities of all kinds, including the disabilities caused by lead poisoning. In 
many respects, this is the kind of public health research one might want to 
59. One does not have to accept this statement as the empirical truth to accept this statement as part of 
the context of the research. In point of fact, the researchers involved in this study had received a previous 
grant on lead abatement that led to the grant at issue in the case. See Larry I. Palmer, Genetic Health and 
Eugenics Precedents: A Voice of Caution, 30 Fla .. St. U.L Rev. 237, 245 (2003). · 
60. Kennedy Krieger, 782 A.2d at 819. 
61. Palmer, supra note 59, at 250. 
62. Kennedy Krieger, 782 A.2d at 811-12. 
63. /d. at 820. 
64. /d. at 819. See also, Lead Paint Poisoning of Children: Progress and Misplaced Self-
Congratulation, EJ ACTIVIST (The Sierra Club, Prescott, Ariz.), Oct. 2004, at 1-2, available at 
http://www.sierraclub.org/ej/downloads/Oct_2004.pdf (last visited Nov. 9. 2008) (discussing various 
approaches to lead abatement). · 
65. Palmer, supra note 59, at n. 67. 
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encourage since it is so steeped in the practical problems policy makers face. 
Presumably, the more economical the means of removing lead to label housing 
"healthy," the more healthy housing would be available for low-income renters. 
Despite these noble goals, the courts used the case to make two institutional 
points. First, the regulatory framework for human subjects established by the 
federal government had failed, in the court's view, perhaps because it had been 
captured by the researchers themselves. The court spent considerable time 
analyzing and critiquing the working of the Institutional Review Board at Johns 
Hopkins66 and was perhaps even aware of the fact that Johns Hopkins' internal 
regulatory process for protecting subjects of research had been recently criticized 
by the federal government. 67 The dissent and concurring judge invited the 
legislature to join the discussion by narrowing the scope of the court's opinion.68 
The state legislature did react to the decision, but not in the way the researchers or 
the dissent and concurring judges might have wanted. The legislature sought to 
create public awareness of the working of IRBs by requiring minutes of 
institutional review boards, with the names and other private information 
redacted, to be made available to the public after those meetings. 69 Thus, one 
aspect of the political regulatory process in effect affirmed the idea that 
something was malfunctioning in the research regulatory system and sought not a 
solution., but more data or knowledge about the actual process. 
The other participants in the knowledge-creation market, the research commu-
nity engaged in housing research, were in fact quite upset by the court's ruling 
and convinced the three major funders of this type of research to fund a study. 
The U. S. Department of Housing and Urban Development, the CDC, and the 
EPA requested that the National Research Council and the Institute of Medicine 
of the National Academic of Sciences conduct a study entitled "Ethical 
Considerations for Research on Housing-Related Health Hazards Involving 
Children. "70 One recommendation of the study provides additional post -litigation 
evidence that something is awry with the research oversight process. The re-
port suggests that the "community" should be involved in the design of the 
health-related housing research.71 The ~mplication of this recommendation is that 
the professionals must lose their monopoly on knowledge-creation in the healthy 
housing debate in line with other recommendations to "democratize the research 
process,'.n particularly as it relates to low-income residents. 
66. Kennedy Krieger, 782 A.2d at 849-52. 
67. See Palmer, supra note 59, at n. 81. 
68. Kennedy Krieger, 782 A.2d at 862 (Raker, J., concurring in part, dissenting in part). 
69. H. Res. 917, 416th Sess. (Md. 2002). 
70. See ETHICAL CONSIDERATIONS FOR REsEARCH ON HOUSING-RELATED HEALTH HAzARDs, supra note 
19. 
71. !d. at 2. 
72. There is perhaps a growing awareness of the need to "democratize" research through community 
participation. See GREENWOOD & LEVIN, supra note 20, at 175-78. Even the federal government is calling 
for "Community-Based Participatory Research." In a recent request for proposals to establish multi-
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Of course, the researchers might see the report's recommendations and call for 
a systems approach to research oversight in housing research as adding to the 
costs for doing this type of research. The court is not unmindful of those costs, 
but it is responding to what one might see as a major shift in "the political 
equilibrium" in the market for knowledge creation about healthy housing. In 
asserting a policy role in the urban healthy policy space, the court is engaging in 
raising questions rather than providing answers. Some of the questions that might 
need to be addressed in healthy housing research are: 
• Under what circumstances would an urban community attempt less than full 
abatement after Kennedy Krieger and the 10M reports on the ethics of this 
type of research? The costs effectiveness of lead abatement is still an issue to 
be resolved. 
• Will the leaderShip for such efforts come from "social entrepreneurs" who 
could garner the human and other resources to further research on the most 
cost effective and ethical methods of creating healthy (not necessarily 
lead-free) housing? 
• Would such research necessarily involve some forms of "community 
participatory action research?"73 
• Could the goal of preventing disability in children of low income coexist with 
the goals of actors in the private market interested in "urban revitalization?" 
Wholesale destruction of all the houses with lead paint; or for that matter, lead 
pipes-"urban renewal"-is no longer viewed as a viable option for social 
policy, particularly when there are tax incentives at the local, state, and federal 
level for private investments in some, but not all, older urban neighborhoods. 
Courts can in some situations perform an important health policy function by 
effectively refrarning issues for both market actors and political institutions. 
disciplinary centers to study health disparities, the funding agencies required that each center have at least 
one project that develops, evaluates, or implements one such participatory action research project. See 
Request for Application, Ctrs. for Population Health & Health Disparities, NIH, RFA: ES-02-009 (April 
1, 2002), available at http:// grants l.nih.gov/grants/guide/rfa-files/RFA-ES~02-009.html (last visited Nov. 
9, 2008). At least one of the researchers involved with the lead paint reductions study in Grimes v. 
Kennedy Krieger Institute, Farfel, appears to be involved as a technical consultant to a community based 
group. Se.e Community Environmental Health Resource Center, Consultants and Advisors, http:// 
www.cehrc.org/about/consadv/index.cfm (last visited Nov. 9, 2008). Whether his involvement consti-
tutes the kind of "participatory action research" as defined by Greenwood, however, cannot be 
determined. 
73. "Community-based participatory research" (CBPR) is defined as "collaborative approach to 
research that equitably involves all partners in the research process and recognizes the unique strengths 
that each brings. CBPR begins with a research topic of importance to the community, has the aim of 
combining knowledge with action and achieving social change to improve health outcomes and eliminate 
health disparities." See Community-Campus Partnerships for Health, http://depts.washington.edu/ccphl 
cornmbas.htrnl (last visited Nov. 9, 2008). 
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ill. POLICY DEVELOPMENT VS. POLICY MAKING: DISEASE SURVEILLANCE AND 
VACCINATION IN THE "NEW PuBLIC HEALTH" 
Kennedy Krieger illustrates how courts can frame a question for society 
without asserting that the court is the ultimate policy maker or even the 
institutional framer of the issues for most urban health problems. Markets as well 
as political and administrative institutions each have the capacity to become the 
primary framing institution for health problems, depending on the context. Two 
recent controversies--disease surveillance for diabetes in New York City and 
legislation to make the Human Papillomavirus (HPV) vaccine mandatory for 
girls-illustrate the need to distinguish between the role of policy development 
and policy making in the health system. With this examination, we will be able to -
discern that the court in Kennedy Krieger was actually engaged in the process of 
policy development within the overall health system. 
A. The Health System and Chronic Disease Surveillance: the Case of Diabetes 
New York City's disease surveillance system for diabetes at one level revives 
the debate between proponents of the "old public health" and those who support 
"new public health."74 Those who frame the· growth rate of diabetes in these 
terms often perceive major legal issues in terms of risks to privacy or liberty 
interests and overall population health. 75 Within this framework, the question for 
political institutions, in this case the New York City legislative body and its 
public health authority, is whether a traditional public health law tool-creating 
regulation that obliges health care providers to report patient information-
should be used for chronic diseases such as diabetes. The assumption is that if 
surveillance was one of the legal tools used to reduce the incidence of infectious 
diseases, legally mandated surveillance would probably be equally effective at 
mobilizing the society to deal with the "epidemic" of diabetes. 
This framing of chronic disease surveillance ignores the growing body of 
knowledge that encourages systems-thinking in analysis of health problems.76 
Systems-thinking requires a concept of a health system that understands the 
74. See supra note 21 and accompanying text. 
75. Even critics of New York City's program frame the issues in terms of balancing. See Wendy K. 
Mariner, Medicine and Public Health: Crossing Legal Boundaries, 10 J. HEAL Til CAREL. & PoL'Y 121 
(2007). The proponents of New York City's chronic diseases surveillance program simply strike a 
· different balance. See, e.g., Lawrence 0. Gostin, "Police" Powers and Public Health Paternalism: HIV 
and Diabetes Surveillance, HASTINGS CENrER. REP., Mar.-Apr. 2007, at 9. 
76. The Institute of Medicine has been a pioneer in promoting a systems approach to the quality 
problem in the health system starting with its reports on patient safety. See INsTITIJTE OF MEDICINE, To 
ERR IS HUMAN: BUILDING A SAFER HEALTH SYSTEM, {Linda T. Kohen et al. eds., 2000) and COMMITTEE ON 
QUALITY OF HEALTH CARE IN AMERICA, INSTITIJTE OF MEDICINE, CROSSING TilE QUALITY CHASM: A 
HEALTH SYSTEM FOR TilE 21"' CENTURY NATIONAL ACADEMY PREss {2001). Even its recent reports on 
problems involving research emphasize a systems approach. See, e.g., INsTITIJTE OF MEDICINE, ETHICAL 
CONSIDERATIONS FOR REsEARCH INvOLVING PRISONERS (2006). 
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differences and inteqelationship between the subsystems of public health and 
health care delivery system. I propose the following schema as a starting point for 
describing and providing an alternative approach to the problem of diabetes 
management: 
Health System 
FIGURE. 
Think of the health system as all of the things that might support the health of 
individuals in a given society. At the basic level, we would know that the 
availability of water, food, shelter, and caregivers for infants and children form 
the components that suppo!-1 the health of a society. There are many factors 
influencing how those various systems are organized. For instance in a 
technologically advanced society such as ours, some might argue that our food 
system is a factor in the rise in obesity.77 
We also know that public infrastructure such as sewer systems, immunizations 
against infectious disease, and even parks and sidewalks influence the overall 
level of health in a society or a community.78 This is a starting definition of what 
is pictured as the public health system in the graphic above. It does not 
77. See, e.g., Adam Benforado, Jon Hanson, & David Yosifon, Broken Scales: Obesity and Justice in 
America, 53 EMORY L.J. 1645, 1793-94 (2004). The authors argue that cheap- and subsidized com 
production encourages the over-production of com, leading to the widespread use of cheaper com syrup 
as a substitute for sugar in all kinds of goods. Rather than reduce the price of soda, for instance, cheaper 
com syrup allows manufacturers of soda to increase the size of soda from seven ounces to twenty ounces. 
78. Richard J; Jackson & Chris Kochtitzky, CENTERS FOR DISEASE CONTROL AND PREVENTION, 
CREATING A HEAL THY ENVIRONMENT: THE IMPACT OF TiiE BUILT ENVIRONMENT ON PuBLIC HEALTH (200 1 ). 
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necessarily matter that for a particular purpose the discussion of public health 
"expands" from its traditional base and tries to engage the issue of whether it is 
safe to use the park for walking under the systems view I propose. It would help 
to point out, however, that there are legal limitations on the extent to which public 
health officials can "mandate" that parks be safe. More important, this analysis 
emphasizes the role of public health agencies in providing health data on issues 
that are sometimes contentious, such as local smoking ordinances as part of the 
prevention _function traditionally assigned to public health as a distinction from 
health care delivery, particularly physicians, who "treat" diseases. 
Our modem health care delivery system, however, has started to assume, at the 
individual level, some of these traditional functions, like prevention or smoking 
cessation. This blurring of the distinction between what is a public health 
function and what is a health care delivery function occurs not because the health 
care delivery system is necessarily more effective at prevention. Rather, the 
blurring of the distinction is a result of the private and public investment in the 
health care delivery system over time. Given the way health care delivery is 
organized and financed, the resources that are counted as "health care costs" are 
currently concentrated in the health care delivery system. For lawyers, it is 
_ important to remember that the current structure of our health care delivery 
system is not simply ·a reflection of "market forces" but also a function of the 
incentives provided by the legal structure.79 
This systems view would allow us to reframe the efforts ofNew York CiW's 
public health department to create more "effective" diabetes management by 
delivering individual patient information to patients and their physicians as part 
of the health care delivery system. The city seeks to achieve its public health goal 
by requiring laboratories to report glucose levels to the public health depart-
ment. 80 The hope is that when patients and physicians then receive information 
indicating that diabetes management techniques have been ineffective, they will 
be prompted to take positive steps toward "good" control. The city pi~oted this 
program in the South Bronx, one of the most disadvantaged parts of New York 
City, presumably on the theory that if it could work there, it could work 
anywhere.81 
Given what we know about the factors influencing diabetes rates, I propose 
that the Department confused its role as policy maker with its role as policy 
developer. For a variety of reasons, diabetes management, even for the poorest of 
79. See PoRTER & TEISBERG, supra note 29, at ch. 8. Chapter 8 has a bold list of reforms necessary to 
change the health system including eliminating the notion that the physician are legally always 
independent contractors-the "corporate practice of medicine doctrine." 
80. I am deliberately ignoring the details of whether the patiept needs to consent to this transfer of the 
information so passionately debated in the public health and bioethics literature. For a detailed account of 
this debate, see sources cited supra note 17. I will also not address the question of whether the public 
health exceptions in the HIPPA regulations are broad enough to exempt the public health department's 
request for the electronic transfer of data. 
81. Roll-out in South Bronx Planned, NYC Diabetes Newsletter, Issue 1, Spring 2007, at 1. 
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our urban residents is a function that is now centered in the health care delivery 
system. The actual capacity of publicly managed clinics and hospitals has been 
dramatically reduced as public funds-Medicare and Medicaid-have been 
shifted to hospitals, nursing homes, and other health care service providers. The 
prominence of buzz words such as "public/private partnerships" and "new form 
of health governance" to refer to health care delivery systems reflects this 
dramatic change in the market for health services in recent years. To put it 
bluntly, public health programs that encourage people with diabetes to exercise 
without access to the most appropriate medications and professional knowledge 
about diabetes management and risks seems a cruel joke. 
The New York City program and its supporters might counter this critique by 
pointing out that their program is aimed at the most disadvantaged communities82 
and will reach those individuals with access to the health care delivery system. 
Furthermore, it helps those with diabetes who have not yet been diagnosed. The 
surveillance approach of this program, however, seems to be based on the theory 
that lack of knowledge is the main factor limiting good decisions, and that the 
public health system can provide the needed knowledge to patients and their 
physicians. This theory reflects the idea that data or knowledge automatically 
drives policy. 
Before other urban communities consider adopting the New York model, let 
me propose an alternative use of our limited resources. The public health 
department should have considered developing partnerships with a variety of 
health care delivery practices in distressed areas in order to uncover the actual 
barriers to "good" diabetes management in those populations. In addition, the 
department should have examined whether or not it had the legal authority to 
develop a c9mpetitive grant process that would encourage health care delivery 
organizations to develop new ways to meet patient needs. · For instance, 
healthcare practitioners may have been able to develop new ways of addressing 
"diabetes self management"83 using new technologies in a low-income commu-
nity. There are a host of issues involved in diabetes self-management that range 
from whether Medicaid will pay for daily testing to who will absorb the cost of 
"diabetes educators." 
Furthermore, there is another looming problem which has not been systemati-
cally studied in the inner city context, namely constraints on access to health care 
delivery-as distinct from access to health insurance. Public health agencies, as 
the sponsors of "organizational experiments," are well-positioned to stimulate 
new professional analysis of how to effectively deliver health care. Indeed, these 
agencies understand the fundamental problem of health care: that the outcome of 
a service depends not simply on physician performance but also on how the 
82. Goslin makes the point that it is cruel, especially on the HIV I AIDS front, to make sure that the 
disadvantaged do not get the best treatments. See Gostin, supra note 75, at 10. 
83. See generally Larry I. Palmer, LAW, MEDICINE, AND SOCIAL JUSTICE (Westminster/John Knox 
Press) (1989). 
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patient responds to his encounter with the health care delivery system. I propose 
that the public health care system needs a new type of data that can only be 
produced by comparing and contrasting the results of providing services to the 
disadvantaged with the highest quality outcomes being produced in the arena of 
diabetes management. 
The disproportionate burden of diabetes on disadvantaged groups should not 
blind us to the need for system level change or the need for lawyers to help 
discover the legal barriers to more effective systems-functioning in the health 
care delivery system. This means there will be a period of policy development to 
discover the most effective methods of change, in contrast to old-fashioned 
health policy which takes the form of rules and mandates. This will require 
careful attention to how new knowledge is developed from data, and how to 
protect the interests of the individuals involved. Accordingly, throughout this 
process lawyers should ask themselves the following questions: 
• Would comparative knowledge about actual "organizational performance" 
encourage health .care providers to innovate as a means of achieving 
"quality" improvements in chronic disease management? 
• Is there a danger that the public costs, as presently measured, will lead to 
mandatory disease management for the poor and those underserved by the 
health care delivery system? 
• What type of data about health care delivery organizations will make them 
accountable to their patients and to the public? 
B. Vaccine Policy in the Genomic Era: The HPV Vaccine 
Only one state has made the new HPV vaccine "mandatory," despite intense 
lobbying by various groups across the country, with financial support from the 
vaccine manufacturer, Merck. 84 Political opposition to state legislation proposed 
to require the vaccine became entwined with the debate over termination of 
pregnancy and other female reproductive health practices. The interest group 
analysis proposed by comparative institutional analysis scholars, 85 however, 
instructs us not to dismiss these intense feelings or personal sensibilities as 
non-scientific fears, as some commentators have done. 86 Rather, we should 
examine the HPV vaccine debate in light of new market conditions that have 
84. Vrrginia passed a law in early 2007 requiring mandatory vaccinations for girls entering the sixth 
grade but also granted parents generous "opt-out" provisions. See VA. CooE.~Im. § 32.1-46 (2008). See 
also Lawrence 0. Gostin & Catherine D .. DeAngelis, Mandatory HPV Vaccination: Public Health v. 
Public Wealth, 297 JAMA 1921, 1921 (2007); Tim Craig, Kaine Says He'll Sign Bill Making Shots 
Mandatory, WASH. PosT, Mar. 3, 2007, at B10; Stephanie Saul & Andrew Pollack, Furor on Rush to 
Require Cervical Cancer Vaccine, N.Y. TiMEs, Feb.l7, 2007, at AI. 
85. See KOMESAR, supra note 14. 
86. See generally R. Alta Charo, Politics, Parents, and Prophylaxis-Mandating HPV Vaccination in 
the United States, 356 NEW ENG. J. MED. 1905, 1905 (2007). 
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changed vaccine development. The advent of genomics and the ability to 
interrupt disease processes in new ways is one of those market forces. As I have 
suggested elsewhere, the knowledge-creating enterprise, science, is itself an 
important institutional force shaping the health care deli very system. 87 In 
addition, the widespread use of patenting, even among university researchers,88 
will make vaccines relatively expensive initially as compared to earlier vaccines 
such as polio. We should remember that Jonas Salk, inventor of one of the earliest 
polio vaccines, refused to patent his discovery. 89 The strong emotions about HPV 
on all sides of the political spectrum and the economics of new vaccine 
development make it a good example of the "supply and demand of rights" in 
health policy making.90 
Reframing the HPV vaccine debate in terms of institutional choice illustrates 
the importance of having an interactive analysis of political processes and 
courts-what I call "institutional balance." The primary focus of this interaction 
thus far in the literature on mandatory vaccination is on the issue of whether 
"religious exemptions" are constitutional.91 As we move into the genomic era92 
of vaccine development, it becomes apparent that market ·forces, including the 
use of intellectual property law, have made more visible the issues of costs. 
Courts may be called upon to decide a new constitutional issue: Are political 
bodies that decide to enact mandatory vaccine laws required to provide indigents 
free vaccines? The drafters of the only "mandatory" HPV vaccine law thus far 
anticipated this possible "equality" claim by conditioning the effective date of the 
mandate on the legislature appropriating adequate funds for indigent girls.93 The 
drafters of the law were undoubtedly aware that previously the political process 
had neglected to provide such funding. The federal government established a 
reimbursement program to the states in exchange for their enactment and 
enforcement of federal vaccine regulations. 94 However, the existence of a federal 
funding program does not mean that funds allocated for the vaccine program 
necessarily meet existing needs95 prior to the introduction of HPV. These issues 
87. See PALMER, supra note 51, at ch.l. It is worth noting that the co-winner of the Nobel Prize in 
Medicine or Physiology in 2008 was the person who discovered the HPV virus that causes cervical 
cancer. See Press Release, The Nobel Assembly at Karolinska Institutet (Oct. 6, 2008), available at 
http://nobelprize.org/nobel_prizes/medicine/laureates/2008/press.html (last visited Nov. 9, 2008). 
88. See Amy R. Schofield, The Demise of Bayh-Dole Protections Against the Pharmaceutical 
Industry's Abuses of Government-Funded Interventions, 32 J.L. MED. & ETiiiCS 777 (2004). 
89. See Jonas Salk Biography, Academy of Achievement, available at http://www.achievement.org/ 
autodoc/page/salObio-1 (last visited Nov. 9, 2008). 
90. See KoMESAR, supra note 14. 
91. See, e.g., Gostin & DeAngelis, supra note 84, at 1922. 
92. See Palmer, supra note 24. 
93. See VA. CODE ANN.§ 32.1-46(A}(l2} (2008). 
94. See Public Health Service Act, 42 U.S.C. § 247(b)) (West Supp. 2008); 42 C.F.R. § 51b.204 
(2007). 
95. See Grace M. Lee et a!., Gaps in Vaccine Financing for Underinsured Children in the United 
States, 298 JAMA 638 (2007). 
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of underlying costs led some proponents of a mandatory HPV vaccine to drop 
their support when faced with the possible impact on an additional HPV mandate 
on their state Medicaid budget.96 This tradeoff between existing programs and a 
proposed new program is not that unusual. 
What is unusual concerning the Virginia mandatory HPV vaccine is the 
manner in which "rights" were also part of the legislative tradeoffs. On its face, 
the new statute adds HPV as one of the vaccines required for school attendance, 
with respect to female students. However, additional statutory provisions create a 
special exemption applicable only to HPV, allowing parents to opt out of the 
mandate without claiming a religious or philosophical objection to vaccines as a 
general matter.97 This statutory exemption-a legislative "right"-illustrates · 
how the supply and demand for "rights" will likely play out along side the hidden 
resources questions in the market for vaccines and government funding: Those 
parents who both agree with the health benefits of HPV and have health resources 
in the form of private insurance will have their daughters vaccinated. 
Merck's extensive lobbying efforts for "mandatory" HPV vaccine laws in fact 
were aimed at getting information about the vaccine to this particular group--the 
willing insured. Merck is not naive enough to believe it· could overcome the 
intensive opposition to laws that appear to condone or admit that teenagers might 
be sexually active. Rather, the sponsorship of bills throughout the country could 
be viewed as the first phase of its consumer advertising program for its vaccine in 
advance of the arrival of a rival vaccine by a competitor.98 On the other hand, 
those parents with strong concerns about the health or moral risks of the HPV 
vaccine are likely to opt out of the vaccine requirement, and, if indigent, are 
unlikely to draw on public funds. If the parents who opt out are generally less 
wealthy than those who obtain the vaccination, the net effect of this optimization 
is that the "most vulnerable" will not receive the vaccine.99 This disparity cannot, 
unfortunately, be overcome through the enactment of mandatory vaccination 
laws. 
In any event, technological advances have in essence led to a transformation of 
the meaning of the term "vaccine." Scientists are not simply trying to prevent the 
transmission of diseases through person-to-person contact. HPV clearly is 
infectious, but the "endpoint" of the HPV vaccine is the prevention of cervical 
96. See, e.g., Laura Ungar, Requiring Vaccine for Ky Girls Unlikely, COURIER-JOURNAL, Mar. 7, 2007, 
at l A (reporting that the bill requiring mandatory HPV vaccination is stalled in the Senate Appropriations 
and Revenue Committee because of opposition to reopening the state budget). 
97. See VA. CODE ANN.§ 32.1-46(0)(1) (2008). 
98. See Merck Launches National Advertising Campaign for Gardasil®, Merck's New Cervical 
Cancer Vaccine, Bus. WIRE, Nov. 13, 2006, available at http://findarticles.com/p/articles/rni_mOEIN/ 
is_2006_Nov_l3/ai_nl6836248/pg_l ?tag=artBody;coll (discussing Merck's extensive advertisement 
campaign launched prior to the arrival of its competitor vaccine, GlaxoSrnithKlein's Cervarix®). 
99. Cf Larry I. Palmer et al., Chemopreventive Drug Treatment in Subjects with Genetic Predisposi-
tion to Cancer: Prescriber.Liability and Health Care Disparities, 5 P!iARMACOGENOMICS 319 (2004) 
(explaining how courts may use liability doctrines to raise questions about the intersection of health 
disparities and medical technologies that may prevent certain kinds of cancers). 
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cancer. The HPV vaccine symbolizes progress in the molecular understanding of 
cervical cancer, and this progress is transforming the idea of "prevention." The 
vaccine is thus one of several tools for prevention used by women. Other tools 
include medical screenings such as the Pap smear and steps to decrease the risks 
of transmission through sexual practices. These alternative forms of prevention 
mean cervical cancer has a much greater impact in the less developed and 
resource-constrained nations of the world than it does in the United States and the 
industrialized West. This type of global disparity leads to a new question: Will 
private actors such as the Bill & Melinda Gates Foundation become the 
"knowledge entrepreneurs" who bring together pharmaceutical companies, 
governments, and international financial institutions to establish subsidies for the 
HPV vaccine, and who decide which countries to target?100 Domestically, we 
need to rethink the role of law-courts, legislatures, and administrative agencies 
-in assuring access to public health measures such as vaccines, 101 while 
struggling with the demand and supply of resources and rights. As we start to 
consider these issues of access, we may find that courts will shift away from 
"liberty" concerns to "equality" concerns in judging the constitutionality of 
public health legislation. 102 
IV. URBAN HEALTH POLICY RESEARCH: PROFESSIONAL KNOWLEDGE, 
CARDIOVASCULAR DISEASE RISK, AND RESEARCH 
Nowhere is the framing of the issue in urban health policy by legal institutions 
and lawyers more important than in cardiovascular disease. On the one hand, we 
are bombarded with data indicating cardiovascular disease is the leading cause of 
death in the United States, and presumably associated with individual behaviors 
such as smoking, improper diet, and obesity. 103 In a simple model of health 
policy where data drives policy, one would focus on determining which legal 
tools would assist the public health prevention function. On the other hand, the 
actual death rate from cardiovascular diseases in the United States has fallen 
dramatically over ~he past quarter of a century, primarily due to a decrease in 
risk-creating behaviors such as smoking, and due to innovations in treatment of 
100. See, e.g., Sue J. Goldie eta!., Cost Effectiveness of HPV 16, 18 Vaccination in Brazil, 25 VACCINE 
6257 (2007) (study was funded by the Bill & Melinda Gates Foundation). 
101. The Virginia statute on immunization appears to grant the state board of health to enact 
regulations to accord with the CDC recommendations in § 32.1-46: 'The required immunizations 
... shall be those set forth in the State Board of Health Regulations for the Immunization of School 
Children." VA. CoDE ANN. § 32.1-46(A) (2008). Even though in theory the State Board could have 
enacted regulations requiring HPV, it was perhaps wise to let proponents go to the legislature for 
mandatory HPV. 
102. Cf Daniel Markovits, Quarantines and Distributive Justice, 33 J. L. MED. & ETHICS (2005) 
103. ARlALDI M. MiNJNo ET AL., CTR. DISEASE CONTROL, DEATHS: FINAL DATA FOR 2004 (2007) (citing 
cardiovascular disease as the leading cause of death in the United States). 
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various forms of cardiovascular diseases. 104 As long we are reducing the risk 
factors for cardiovascular disease and developing new and more effective 
therapies, the age-adjusted death rate will continue to fall. Public health scientists 
have concluded that the declining death rate is due in equal parts-50% each:--to 
the reduction of risk factors and to new and more effective treatments. 105 One 
therefore could draw the optimistic conclusion that current health policies are 
moving us in the right direction. We could further assume that the health policy 
process and law's role in that process are currently optimal for addressing the 
complex problem of cardiovascular disease. 
I propose two reasons for rejecting this optimistic view of the cardiovascular 
disease health policy process. First, data about health outcomes in our current era 
of evidence-based therapies cannot be evaluated without considering the looming 
problem of costs in the health system. New therapies, and even the reduction of 
risk factors in some cases, 106 initially are perceived as costly. For instance, 
reducing the effects on air pollution lowers the risks of cardiovascular disease in 
some populations, 107 but those reductions are often viewed as costly. Further-
more, the relatively new field of "medical economics" has begun to analyze the 
relative cost effectiveness of various approaches to cardiovascular disease 
treatment and management. 108 As the economic analysis of the cost of any 
particular intervention becomes a part of the mainstream political discourse, a 
legal framework without a space for cost analysis becomes more problematic. 
Second, "health disparities" or "health inequities" are hidden in the overall 
health outcome and cost figures used to describe "progress" in cardiovascular 
diseases. There is a lot of data that informs us that the most vulnerable members · 
of our society, particularly in urban areas, are exposed to a greater share of the 
burden of disease. It comes as no surprise, for instance, that some data suggests 
an association between crime rates, unemployment, and cardiovascular dis-
ease. 109 More significant, it should come as no surprise that despite political and 
scholarly rhetoric about eliminating health disparities, very little progress has 
been made-by almost any measure--over the past decade. 110 Setting as a 
104. See Earl S. Ford et al., Explaining the Decrease in U.S. Deaths from C(Jronary Disease, 
1980-2000, 356 NEW ENG. J. MED. 2388 (2007). . 
105. ld. 
106. See Barak D. Richman, Behavioral Economics and Health Policy: Understanding Medicaid's 
Failure, 90 CoRNELL L. REv.705, 765-67 (2005) (describing the difficulties incorporating the true social 
and psychological costs of preventative services into the Medicaid program in the states). 
107. See Douglas W. Dockery & Peter H. Stone, Cardiovascular Risks from Fine Particulate Air 
Pollution, 356 NEW ENG. J. MEn. 511 (2007). 
108. See Daniel B. Mark & Mark A. Hlatky, Medical Economics and the Assessment of Value in 
Cardiovascular Medicine: Part 11, 106 CIRCULATION 626 (2002). 
109. See Kristina A. Sundquist et al., Neighborhood Violent Crime and Unemployment Increase the 
Risk of Coronary Heart Disease: A Multilevel Study in an Urban Setting, 62 Soc. SCI. & MED. 2061 
(2006). 
110. See Rebecca Voelker, Decades of Work to Reduce Disparities in Health Care Produce Limited 
Success, 299 JAMA 1411 (2008). See also M. Gregg Bloche, Health Care Disparities-Science, Politics, 
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national goal "eliminating health disparities" by 2010111 does not seem to lead to 
measurable progress. 
One response to the suggestion that "progress" in dealing with cardiovascular 
disease has not dealt with the elephant in the room-health disparities-is simply 
to call for more research to eliminate disparities. Presumably, if the professionals 
in the health care delivery system knew more about the causes of the disparities 
and the health professional workforce became more diverse, the diffusion of 
professional knowledge throughout ·the health system would stimulate the 
discovery and elimination of policy barriers to a more just distribution of the 
burdens of disease. But even proponents of this view are starting to wonder about 
the effectiveness of accumulating knowledge without a conceptual framework to 
link an increase in knowledge with some type of policy process that is 
accountable not only to the agencies funding health research, but also to those 
individuals and communities that are most at risk. Increasingly, there are 
calls-but not necessarily additional funding-for "community-participatory 
action research" as a way to increase the effectiveness of the health equity 
movement. 112 These quandaries about health disparities signal a failure to frame 
a complex problem in a fashion that highlights the trade-offs involved and the 
ethical dilemmas we need to address as citizen/lawyers. 113 The underlying ethical 
dilemma I have identified in cardiovascular treatment and research is that we may 
develop new treatments that improve overall health outcomes without addressing 
the disparities in outcomes between the majority of Americans and those urban 
populations that are most vulnerable. 
Let me illustrate this point by sketching how different the policy questions 
appear from my perspective by focusing on cardiovascular assist devices over 
time. Dr. Denton Cooley's implantation of the first implantable artificial heart in 
the late 1960s led to litigation over whether the patient/human subject had given 
adequate "informed consent."114 Regulatory oversight of the use of these new 
devices grew out of the ethical concerns about the appropriateness of one 
surgeon-admittedly a very skilled one-nonetheless being the sole decision 
maker in using an experimental device. In addition, some proponents of 
regulations hoped that supervised clinical trials could make these devices more 
effective over time, even if their initial costs would be so high that few could 
and Race, 350 NEw. ENG. J. MED. 1568 (2004) (indicating that political considerations can influence the 
federal reporting of the health disparities data). · 
11~. Healthy People 2010, http://www.healthypeople.gov/About/goals.htm (last visited Nov. 9, 2008). 
112. See generally CoMMUNITY-BASED PARTICIPATORY REsEARCH FoR HEALTH (MEREDITH MINKLER 
ET AL. EDS., Jossey-Bass 2003). 
113. A symposium of the William & Mary Law Review held on February 8-9, 2008 critically examined 
the idea of the "citizen lawyer." See http://law.wm.edu/academics/intellectuallife/researchcenters/ibrU 
pastevents/symposia/index.php (last visited December 15, 2008). The implications of how the 
citizen/lawyer idea would change legal education were explored by one of the participants. See Edward 
Rubin, The Citizen Lawyer and the Administrative State, 50 WM. & MARY L. REv. (forthcoming 2009). 
114. See Karp v. Cooley, 493 F.2d 408 (5th Cir.l974). 
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afford them. 115 This problem of equitable distribution of the benefits of 
cardiovascular innovation was highly visible, at least to scholars in 1970s, 
because of scarcity problems regarding human hearts for transplantation. 116 
Fast forward a few decades and the ethical issues have been transformed by 
technological progress in the effectiveness of heart assist technology as well as a 
change in the institutional processes. The new regulatory environment for 
medical devices seems to have eliminated the specter of a surgeon implanting a 
heart device without any constraints. For a variety of reasons, not to be developed 
here, the Food and Drug Administration required clinical trials. The AbioCor 
implantable heart illustrates this practice, even though only eight patients were 
approved for the first round of trials. The complex system of ethical review 
established by the manufacture for these transplantation trials 117 further indicates 
an acceptance of "ethics" as a part of the health policy process . 
. A more significant change is the fact that the providers' "market"-manu-
facturers, physicians, and payers-has accepted the idea that a heart devices' 
effectiveness should be determined through large scale "clinical trials" as defined 
by epidemiologists rather than clinicians, the reporting of which has· to some 
degree been professionalized by the establishment of standards for reporting 
randomized clinical trials. 118 The implantable cardioverter defibrillator (ICD) is 
an example of an assist device whose effectiveness in reducing the risk of heart 
attack by monitoring and stimulating heart rhythms has been extensively studied. 
The electronics and mechanics of ICDs have constantly improved and the risks of 
implantation diminished over the past twenty-five years. Various manufacturers 
now produce ICDs, with costs of a single implantation around $25,000. 119 Vice 
President Cheney's highly publicized periodic check-ups of his ICD have helped 
to make the avoidance of a heart attack part of the health policy discourse in this 
country. 120 
Recent randomized clinical trials have indicated the potential benefits of ICDs 
for certain patients at risk of heart attacks. The Food and Drug Administration has 
already approved the use of ICDs for those who previously suffered and survived 
a heart attack. 121 But with a 38% mortality rate for U.S. heart attack victims (new 
115. See SandeepJauhar, The Artificial Heart, 350 NEW ENG. J. MEo 542 (2004). 
116. See generally GUIDO CALABRESI & PHiuP BoBBilT, TRAGIC CHOICES (1978). 
117. See E. Haavi Morreim, The Case of the AbioCor Heart, HASTINGS CENTER. REP., JAN.-FEB. 2004, 
at 11. 
118. See http://www.consort-statement.org/ (last visited Dec. 15, 2008) 
119. Mark A. Hlatky et al., Evidence-Based Medicine and Policy: The Case of Implantable Cardio-
verter Defibrillator, 24 HEALTH AFF. 42 (2005). 
120. See, e.g., Cheney's Heart is Deemed Stable: Checkup Find No Problems, WASH. PosT, July 2, 
2006, atA07; Cheney's Heart Device is Working Fine, WASH. PosT., July 9, 2003, atA02; Dana Milbank, 
Cheney to Get Routine Heart Check, WASH. PosT, Sept. 13, 2002, at A04. 
121. See http://www.fda.gov/bbs/topics/ANSWERS/2002/ANS01159.html (last visited Dec. 15, 
2008). 
660 The Georgetown Journal on Poverty Law & Policy [Vol. XV 
and recurrent), 122 we can imagine the pressure on conscientious clinical 
researchers to expand the benefits of ICDs to those patients without prior heart 
attacks. Medicare announced a new payment program for ICDs in the same issue 
of the New England Journal of Medicine that announced the results of the latest 
clinical studies. 123 Medicare conditioned its expansion of payments for some 
patients who had not suffered a heart attack on the patient and physician's 
willingness to become part of registry designed to assist further studies of 
effectiveness.124 
There are three ethical and policy questions raised by this linkage of treatment, 
costs, and increase in professional knowledge through clinical trials. First, a 
Medicare regulatory rule that links payment to participation in the registry 
appears unethical. Traditional thinking about access to health care frowns upon 
this type of "bedside rationing."125 Second, the potential cost of providing this 
one device to all at-risk Medicare beneficiaries would require a large share of the 
entire Medicare budget. In our current political paradigm of "health care cost 
containment" and "no new taxes," a massive infusion of funds into the Medicare 
budget is highly unlikely unless some other federal benefit is drastically 
reduced. 126 Third, once ICDs are installed, we may be creating downstream 
ethical dilemmas when these devices have to be turned off at the request of 
terminally ill patients or their surrogates. 127 Our current way of linking the 
federal public health payment system to the regulation of new devices leads to the 
possibility that Medicare may pay for the implantation of the newest version of 
the AbioCor implantable heart in patients who now are defined as "terminal."128 
A reframing of these questions from the institutional choice perspective argued 
for here allows us to broaden the context of the debate. Widespread use of ICDs 
indicates that prevention has become part of the health care delivery system's 
approach t9 cardiovascular disease. Further, ICDs are only one of many data 
points in judging overall reduction of risks of cardiovascular disease. Second, 
and perhaps most significant, I propose that the over-emphasis on measuring 
costs ignores the larger systemic issue of developing a method of measuring the 
122. See Wayne Rosamond et al., Heart Disease and Stroke Statistics-2007 Update: A Report From 
the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, 115 CIRCULA-
TION e69; e89 (2007). 
123. See Mark B. McClellan & Sean R. Tunis, Medicare Coverage of ICDs, 352 NEW ENG. J. MED. 
222, 222-24 (Jan. 20, 2005). 
124. See id.; A. Kadish, Prophylactic Defibrillator Implantation-Toward an Evidence-Based 
Approach, 352 NEW ENG. J. MED. 285, 285-87 (Jan. 20, 2005). 
125. See REsOLVING ETIUCAL DILEMMAS: A GUIDE FOR CLINICIANS 189-195 (3d ed. 2005). 
126. Cf James F. Blumstein & Frank A. Sloan, Health Care Reform Through Medicaid Managed 
Care: Tennessee (TennCare) as a Case Study and a Paradigm, 54 VAND. L. REv. 125 (2000) 
127. See Rob Stein, Devices Can Interfere With Peaceful Death: Implants Repeatedly Shock Hearts 
Of Patients Who Cannot Be Saved, WASH. PosT, Dec. 16, 2007, at AO 1. 
128. See AbioCor Heart Moves Closer to Medicare Reimbursement, J. NEW ENG. ThCH., Feb. 4, 2008, 
available at http://www.masshightech.com/stories/2008/02/04/daily4-AbioCor-heart-moves-closer-to-
Medicare-reimbursement.html (last visited Nov. 9, 2008). 
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value to patients. The present methods of measuring effectiveness tell us how 
much it costs to manufacture, install, and monitor an lCD in a variety of patients 
with certain types of risks. We do not yet have robust methods of measuring the 
"value-added" to patients of these innovations in heart technologies and disease 
management. Were our studies more patient-centered rather than service 
production centered, our public discourse would be more attuned to the 
distribution of health benefits. 129 Were we more refined in our analysis of the 
combined effects of risks factors and inadequate access to health care services in 
many of our urban communities, we would probably pay more attention to 
relative lack of progress in health outcomes among inner city dwellers. 130 
Changing our thinking from cost to value to patient requires a three-step 
process. The first step is to recognize that health is not a commodity, and neither 
is health care. The second step is to recognize that costs are important in the type 
of measurement I have proposed. Value is essentially the cost over a certain 
period of time. Third, patients and their health providers need information about 
the effectiveness of both interventions and preventive measures, as well as 
information about available providers, in order to d~termine which course is best 
for particular patients. The current system of accounting in health care develops 
costs and effectiveness measures, but seld<;>m adds the relevant timeframe to the 
equation. 
Essentially, this three-step process reveals that our analysis of the health 
system needs to be both more disease-specific and more population-specific. 
Cardiovascular disease treatment and research would have a different set of 
matrixes than certain kinds of cancers, for instance. Both disease areas deal with 
risks and prevention, but the generalizing principle for the developments in each 
area should be "value to patients," not necessarily "the costs" of producing the 
treatment. Patients with chronic risks of heart attack may or may not understand 
the need for ongoing quality improvements in treatments. Given this differential 
in patient knowledge, the ethics of designing registries might involve a 
community outreach function or the selection of centers with appropriate 
diversity among its patient population. Further, the emphasis on value does not 
mean there will not be competition built into the system. 
But rather than compete over costs, the health system should compete over 
value added to patients, adjusted for their risks. This could mean, for instance, 
that those providers dealing with those at greater risks of cardiovascular disease 
could fair better on the measurements than those dealing with lower risk patients. 
A switch to a value basis of measurement of health outcomes would require a 
radical reorganization of the payment system for health care where there are 
129. My discussion of "the value to patients" as the center of analysis of the health care system is 
based on my reading of PoRTER &TE!SBERG, supra note 29. 
130. Cf David Satcher et al., What If We Were Equal? A Comparison of the Black-White Mortality 
Gap in 1960 and 2000, 24 HEALTH AFF. 459 (2005) (describing how the disparities between blacks and 
others have not changed significantly). 
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incentives not for "prevention" per se, but for "value" added to patients. 
Whatever the system of paying for health and health care, the system of 
accountability of the overall system and its component parts must focus on value 
to patients. 
CONCLUSION 
This analysis encourages us to reject commodity-thinking about public health, 
health, and health care delivery. The latter may be a service whose outcome is 
dependent upon both the actions of providers and clients. Those clients have 
various concepts of health and levels of access to health care delivery and public 
health infrastructure such as parks and safe sidewalks. 131 More important, those 
clients live and work in diverse communities, whose social, economic, and 
physical construction may impact the health of their members. 132 
Defining health policy is critical in any context in which we seek to use 
professional knowledge to move actors within institutional processes of the 
overall health system, the government, and the market. Lawyers seeking to use 
their particular skills in this multidisciplinary environment can use comparative 
institutional analysis to frame the issue of institutional choice. They must 
determine which of several imperfect institutions-"the markets," courts, 
legislative bodies, and regulatory bodies-is the forum in which a particular 
problem is currently being addressed before they can address the normative and 
empirical question of whether the current choice is optimal. Most important, 
comparative institutional analysis should equip lawyers to understand how the 
legal system operating at various levels of government shapes the living 
conditions and health of urban populations. It is my hope as a citizen-scholar133 
that such an approach will better enable lawyers to frame the questions from the 
perspective of those living in the most health risky communities in our cities. 
This is, after all, what is meant by the phrase, "community participatory action 
research." 134 
131. See, e.g., Barak D. Richman, supra note 106. 
132. See Nicholas Freudenberg et al., Beyond Urban Penalty and Urban Sprawl: Back to Living 
Conditions as the Focus of Urban Health, 30 J. OF COMMUNITY HEALTH 1 (2005). See also Willian! 
McGreevey et al., Propinquity Matters: How Better Health, Urbanization, and Income Grew Together, 
1870-2008, 15 GEo. J. ON PoVERTY L. & PoL'Y X (2008). 
133. See Joseph Goldstein, Psychoanalysis and Jurisprudence 77 YALE L. J. 1 053-0n the Relevance 
of Psychoanalytic Theory to Law, 23 PsYCHOANALYTIC STUD. Cmw 459 (1968) (discussing how legal 
actors should approach problems in interdisciplinary spaces and encouraging us to distinguish our roles 
as scholars and as citizens). 
134. See GREENWooD & LEVIN, supra note 21. 
